Trial Profile
Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Registrational
- Sponsors Zeria
- 01 Jan 2019 Results published in the International Journal of Hematology
- 04 Mar 2018 Status changed from active, no longer recruiting to completed.
- 24 Mar 2017 Status changed from recruiting to active, no longer recruiting.